COMMUNIQUÉS West-GlobeNewswire

LeMaitre Vascular to Present at Upcoming Investor Conferences

03/05/2018 - 22:15

BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be presenting in three conferences in May. David Roberts, President, is scheduled to present at [...]

Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

03/05/2018 - 22:10

BURLINGAME, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

TESARO Announces First-Quarter 2018 Operating Results

03/05/2018 - 22:05

ZEJULA Q1 net sales totaled $49 million Enrollment completed in Phase 3 PRIMA first-line ovarian cancer monotherapy trial TOPACIO platinum-resistant ovarian cancer and triple-negative breast cancer data accepted for [...]

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018

03/05/2018 - 22:05

RANCHO CUCAMONGA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the Company will release results for its first quarter of 2018 ended March 31, 2018, after the [...]

Adamas Reports First Quarter 2018 Financial Results

03/05/2018 - 22:05

GOCOVRI™ (amantadine) extended release capsules product sales hit $2.6 million for the first quarter of commercialization, with 1,608 fulfilled prescriptions Received positive feedback from the U.S. Food and Drug [...]

SeaSpine Reports First Quarter 2018 Financial Results

03/05/2018 - 22:05

Reiterates 2018 Financial Outlook CARLSBAD, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of [...]

Akcea Reports Financial Results and Highlights for First Quarter 2018

03/05/2018 - 22:05

TTR licensing transaction positions Akcea for two rare disease drug launches in 2018 FDA extended TEGSEDI TM (inotersen) PDUFA date to October 6, 2018 $445 million in pro forma cash to fund the company through key [...]

Fluidigm Announces First Quarter Financial Results and Operational Progress

03/05/2018 - 22:04

Product Innovations in Mass Cytometry and Genomics Total Revenue of $25.2 million, Genomics Revenue Growth of 18 Percent SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM [...]

IRIDEX Announces 2018 First Quarter Financial Results

03/05/2018 - 22:04

MOUNTAIN VIEW, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial results for the first quarter ended March 31, 2018. First Quarter Highlights Cyclo G6™ product revenue [...]

Allscripts announces first quarter 2018 results

03/05/2018 - 22:02

Reported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to [...]

Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update

03/05/2018 - 22:02

FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018 Lebrikizumab Phase 2b study enrolling patients, data expected in first half of 2019 MENLO PARK, Calif., May 03, 2018 (GLOBE NEWSWIRE [...]

Asterias Biotherapeutics to Report First Quarter 2018 Results on May 9, 2018

03/05/2018 - 22:01

FREMONT, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]

Diversicare Announces 2018 First Quarter Results

03/05/2018 - 22:01

BRENTWOOD, Tenn., May 03, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ), a premier provider of long-term care services, today announced its results for the first quarter ended March 31, [...]

Invuity Announces First Quarter Financial Results

03/05/2018 - 22:01

SAN FRANCISCO, May 03, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March [...]

Allscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGrid

03/05/2018 - 22:01

High-impact capabilities expected to enable providers to reach the entirety of their patient populations CHICAGO, May 03, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, [...]

MyoKardia to Report First Quarter 2018 Financial Results on Tuesday, May 8, 2018

03/05/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update

03/05/2018 - 22:01

U.S. and European regulatory meetings scheduled based on positive trilaciclib Phase 2a myelopreservation data Preliminary data from G1T38 Phase 1b trial in breast cancer to be presented at ASCO on June 2 Management to [...]

Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer

03/05/2018 - 22:01

LIVONIA, Mich., May 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]

Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results

03/05/2018 - 22:01

Company Pursuing U.S. Vitaros Partnership and Strategic Alternatives SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company seeking to advance innovative [...]